Abstract: This is to provide a novel medicine and a food and a drink composition for treating aesthenopia excellent in improved effect of aesthenopia. The composition for the treatment of aesthenopia comprises chondroitin sulfate or a salt thereof.

Abstract: A cosmetic composition is provided. The cosmetic composition may include pomace olive oil and a first moisturizing oil. The first moisturizing oil may be safflower oil, mango butter, or hemp seed oil. A second oil can also be included and may be coconut oil or grape seed oil. A bacterial control oil can also be present and may be sweet orange oil or lemongrass oil.

Abstract: A dietary supplement for regulating the appetite of an individual is described. The dietary supplement comprises at least one mechanical satiety regulator, and at least one chemical satiety inducer, and may additionally comprise at least one thermogen, and/or at least one side effect remover. The dietary supplement induces satiety based on a combination of occupying part of the volume of the stomach, inducing sending signals to the brain in respect of satiety. Furthermore the dietary supplement may maintain or increase metabolism and reduce side effects such as the amount of produced flatulence. The dietary supplement may comprise fiber, whey, plant parts from plants e.g. of the genus Capsicum and plant parts from a species e.g. of the genus Mentha.

Abstract: Insecticidal compositions have at least one active agent and at least one insecticide. The active agent can include perilla oil, a component found in perilla oil, or a perillaldehyde or carvone analog. The insecticide can include a pyrethrum, pyrethrin, pyrethroid, neonicotinoid, chlofenapyr, ethiprole, sulfoxoflor, carbamate, organophosphate, or organochlorine. Methods for controlling insects include contacting an insect with an effective amount of a composition described in this specification. Modified plants that produce an active agent can be contacted with an insecticide.

Abstract: The present invention provides compositions of modified pectin and methods for preparing and using them.

Abstract: A topical composition comprising at least one active agent selected from a depilatory agent (s), an agent (s) for preventing or reducing the growth or re-growth of hair and an agent (s) for preventing or reducing in-growing hair, and a gas, wherein the at least one active agent and gas are dispersed in a cosmetically acceptable medium.

Abstract: The present invention provides a novel method for preventing and treating memory and cognitive impairment resulting from oxidative stress, inflammation and the process of aging, as well as, neurodegenerative conditions. The method is comprised of administering a composition comprising a mixture of Free-B-Ring flavonoids and flavans synthesized and/or isolated from a single plant or multiple plants to a host in need thereof. The present also includes a novel method for simultaneously inhibiting expression of pro-inflammatory cytokines, preventing ROS generation and augmenting anti-oxidant defenses. The activity of this composition is conducive to ultimately preserving cognitive function and providing a level of neuroprotection.

Abstract: The present invention provides a composition for accelerating a change in muscle type, increasing the amount of muscle, strengthening muscle, enhancing athletic abilities, reducing lipids, suppressing the accumulation of lipids, lowering blood sugar, controlling body weight or lowering body weight, containing a PPAR-? promoter, an AMPK promoter and a PGC1-? promoter as an active ingredient.

Abstract: The present invention relates to a method of using an anthraquinone derivative namely 9,10-Dihydro-4,5-dihydroxy-9,10-dioxo-2-anthracenecarboxylic acid, or known as Rhein, for treating chronic pancreatitis induced fibrosis of the pancreas. More particularly, the present invention relates to a method of using Rhein, its derivatives and/or chemical variants as an anti-fibrotic agent. The present invention particularly relates to the suppression of pancreatic stellate cell activation for the management of chronic inflammatory, fibrotic and tumorigenic pathologies in the pancreas.

Abstract: The present invention provides a mitochondria regulator composition, which comprises a wild bitter gourd extract. The mitochondria regulator composition can regulate the function of mitochondria in a cell, and further regulate the efficiency of adaptive thermogenesis and energy expenditure in a cell.

Abstract: An insect repellent/insecticide starts with a main composition that is composed of the three primary essential oils of eucalyptus, citronella, and pine. A number of secondary essential oils can be added that provide additional beneficial characteristics, depending upon the application. A safe embedded tick “remove and kill” product includes a basic pH adjuster that is added to the main composition in an amount sufficient to adjust the pH of the main composition to approximately between 6.4 and 7.4, and preferably equal to about 6.5. A repellent spray dilutes the main composition in water to about 1% concentration by volume and a sufficient amount of a basic pH adjuster is added thereto to adjust the pH of the main composition to approximately between 6.4 and 7.4, and preferably equal to about 6.5. Soap includes the main composition combined with a detergent, glycerin, and a sufficient amount of an acidic pH adjuster to adjust the pH of the soap composition to approximately between 6.4 and 7.

Abstract: The present invention relates to a novel use of herbal extracts in a pharmaceutical composition for prevention and treatment of nephritis and, more particularly, to a pharmaceutical composition and a health functional food for prevention and/or treatment of nephritis that contains at least one herbal extract selected from the group consisting of a Crataegi Fructus extract, a Cinnamomi Cortex extract, a Prunella Spica extract, and an Equiseti Herba extract, a method for prevention and/or treatment of nephritis using the herbal extract, and a use of the herbal extract in preparation of a composition for prevention and/or treatment of nephritis. The herbal extract has a good therapeutic effect for nephritis on a nephritis model of which the nephritis is induced by a drug such as gentamicin, cisplatin, etc., and a good inhibitory activity on the growth of mesangial cells in kidneys, thereby providing a very useful means for prevention and/or treatment of nephritis.

Abstract: A natural product energy drink is provided, which synergistically aids in (1) function of the heart, (2) energy production, such as in muscles, and/or (3) enhances removal of toxic free radicals. For example, the natural product energy drink enhances function of the heart, by the use of CoQ10; enables the body to produce more energy through enhanced efficiency of the Krebs cycle, such as by use of L-carnitine; and aids in the removal of waste and/or toxins produced in the body, such as by providing anti-oxidants. Hence, the energy drink synergistically optimizes the heart, muscles, and toxin removal at the same time, which allows the user to prolong duration of exercise, increase intensity of exercise, and recover faster. The natural product, which provides nutrients, is an energy drink that optionally contains no caffeine or sugar while retaining efficacy.

Abstract: An alopecia prevention composition consists of 0.1˜3 weight % of salicylic acid, 0.1˜5 weight % of tocopherol acetate, 0.1˜3 weight % of nicotinic acid amide, 0.1˜1 weight % of polyvinylpyrrolidone, 8˜12 weight % of ethanol, 0.3˜0.5 weight % of polyoxyethylene hydrogenerated castor oil, 0.2˜0.4 weight % of Sophora Angustifolia root extract, 0.2˜0.4 weight % of peony root extract and a residual quantity of purified water.

Abstract: An antiviral composition and a method of treating viral conditions comprising colloidal silver, silver nitrate, or both, and an antiviral natural herb or a natural herb from the Rutaceae family, such as Ruta graveolens, Myrtaceae family, such as Melaleuca alternifolia, Cupressaceae family, such as Thuja occidentalis, and the Moraceae family, such as fig, or any combination thereof.

Abstract: The invention relates to the use of a combination of cannabinoids, particularly tetrahydrocannabinol (THC) and cannabidiol (CBD), in the manufacture of a medicament for use in the treatment of cancer. In particular the cancer to be treated is a brain tumor, more particularly a glioma, more particularly still a glioblastoma multiforme (GBM).

Abstract: Methods for preventing, ameliorating, or reducing dermatological signs of aging are provided which employ active agents, other than a retinoid, that stimulate thymosin beta-4 expression in the skin. Also provided are methods for screening for substances which stimulate thymosin beta-4 expression levels and the methods of using active agents identified by the screening protocol in the treatment of skin.

Abstract: Disclosed is a composition comprising MZ for use as a dietary supplement or food additive for oral consumption for improving the visual performance of a human subject.

Abstract: The present invention relates to herbal medicine extracts useful in the prevention or treatment of diseases caused by influenza viruses, and to a pharmaceutical composition or health food comprising the extracts. The herbal medicine extracts of the present invention are derived from natural materials, and are safe for the human body, and can be used in preventing and treating and in relieving symptoms of diseases caused by various types of influenza viruses.

Abstract: The invention relates to the use of bedstraw extracts that can be obtained by means of extracting using water or water-alcohol solvents or mixtures thereof, for producing a formulation, and for treating or preventing neurodegenerative diseases.